과제정보
This work was supported by the National Research Foundation of Korea funded by the Ministry of Science, Information and Communication Technology, Korea (NRF-2021M3E5E3080540) and the Korea Research Institute of Chemical Technology (Grant No. KKM2232-30). Y.J.K is supported by 'National Research Council of Science & Technology (NST)' - 'Korea Research Institute of Chemical Technology(KRICT)' Postdoctoral Fellowship Program for Young Scientists at KRICT in South Korea.
참고문헌
- WHO Coronavirus (COVID-19) Dashboard. Available from https://covid19.who.int/. Accessed 24 June, 2020.
- Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, et al. 2020. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 183: 739-751.e8. https://doi.org/10.1016/j.cell.2020.09.032
- Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. 2021. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19: 409-424. https://doi.org/10.1038/s41579-021-00573-0
- Huang X, Dong W, Milewska A, Golda A, Qi Y, Zhu QK, et al. 2015. Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme. J. Virol. 89: 7202-7213. https://doi.org/10.1128/JVI.00854-15
- Krempl C, Schultze B, Herrler G. 1995. Analysis of cellular receptors for human coronavirus OC43. Adv. Exp. Med. Biol. 380: 371-374. https://doi.org/10.1007/978-1-4615-1899-0_60
- Schultze B, Herrler G. 1993. Recognition of N-acetyl-9-O-acetylneuraminic acid by bovine coronavirus and hemagglutinating encephalomyelitis virus. Adv. Exp. Med. Biol. 342: 299-304. https://doi.org/10.1007/978-1-4615-2996-5_46
- Maginnis MS. 2018. Virus-receptor interactions: The key to cellular invasion. J. Mol. Biol. 430: 2590-2611. https://doi.org/10.1016/j.jmb.2018.06.024
- Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, et al. 2021. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J. Biomed. Sci. 28: 9. https://doi.org/10.1186/s12929-020-00703-5
- Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. 2006. Nidovirales: evolving the largest RNA virus genome. Virus Res. 117: 17-37. https://doi.org/10.1016/j.virusres.2006.01.017
- Yoshimoto FK. 2020. The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J. 39: 198-216. https://doi.org/10.1007/s10930-020-09901-4
- Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. 2020. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens 9: 186. https://doi.org/10.3390/pathogens9030186
- Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7: 439-450. https://doi.org/10.1038/nrmicro2147
- Forni D, Cagliani R, Clerici M, Sironi M. 2017. Molecular evolution of human coronavirus genomes. Trends Microbiol. 25: 35-48. https://doi.org/10.1016/j.tim.2016.09.001
- Cunningham CH, Stuart HO. 1947. Cultivation of the virus of infectious bronchitis of chickens in embryonated chicken eggs. Am. J. Vet. Res. 8: 209-212.
- Cheever FS, Daniels JB. 1949. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. J. Exp. Med. 90: 181-210. https://doi.org/10.1084/jem.90.3.181
- McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. 1967. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc. Natl. Acad. Sci. USA 57: 933-940. https://doi.org/10.1073/pnas.57.4.933
- Hamre D, Procknow JJ. 1966. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 121: 190-193. https://doi.org/10.3181/00379727-121-30734
- Xu RH, He JF, Evans MR, Peng GW, Field HE, Yu DW, et al. 2004. Epidemiologic clues to SARS origin in China. Emerg. Infect. Dis. 10: 1030-1037. https://doi.org/10.3201/eid1006.030852
- Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367: 1814-1820. https://doi.org/10.1056/NEJMoa1211721
- Tao Y, Shi M, Chommanard C, Queen K, Zhang J, Markotter W, et al. 2017. Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history. J. Virol. 91: e01953-16.
- Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. 2020. Structural basis of receptor recognition by SARS-CoV-2. Nature 581: 221-224. https://doi.org/10.1038/s41586-020-2179-y
- Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. 2020. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367: 1444-1448. https://doi.org/10.1126/science.abb2762
- Wu K, Li W, Peng G, Li F. 2009. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc. Natl. Acad. Sci. U SA 106: 19970-19974. https://doi.org/10.1073/pnas.0908837106
- Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, et al. 2005. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24: 1634-1643. https://doi.org/10.1038/sj.emboj.7600640
- Reguera J, Santiago C, Mudgal G, Ordono D, Enjuanes L, Casasnovas JM. 2012. Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathog. 8: e1002859. https://doi.org/10.1371/journal.ppat.1002859
- Delmas B, Gelfi J, L'Haridon R, Vogel LK, Sjostrom H, Noren O, et al. 1992. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature 357: 417-420. https://doi.org/10.1038/357417a0
- Bonavia A, Zelus BD, Wentworth DE, Talbot PJ, Holmes KV. 2003. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J. Virol. 77: 2530-2538. https://doi.org/10.1128/JVI.77.4.2530-2538.2003
- Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, et al. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495: 251-254. https://doi.org/10.1038/nature12005
- Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, et al. 2013. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500: 227-231. https://doi.org/10.1038/nature12328
- Jackson CB, Farzan M, Chen B, Choe H. 2022. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23: 3-20. https://doi.org/10.1038/s41580-021-00418-x
- Hoffmann M, Hofmann-Winkler H, Pohlmann S. 2018. Priming time: How cellular proteases arm coronavirus spike proteins, pp. 71-98. In Bottcher-Friebertshauser E, Garten W, Klenk HD (eds.), Activation of Viruses by Host Proteases, Ed. Springer International Publishing, Cham
- Millet JK, Whittaker GR. 2018. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology 517: 3-8. https://doi.org/10.1016/j.virol.2017.12.015
- Millet JK, Whittaker GR. 2014. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc. Natl. Acad. Sci. USA 111: 15214-15219. https://doi.org/10.1073/pnas.1407087111
- Hoffmann M, Kleine-Weber H, Pohlmann S. 2020. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell 78: 779-784 e775. https://doi.org/10.1016/j.molcel.2020.04.022
- Takeda M. 2022. Proteolytic activation of SARS-CoV-2 spike protein. Microbiol. Immunol. 66: 15-23. https://doi.org/10.1111/1348-0421.12945
- Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. 2011. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol. 85: 873-882. https://doi.org/10.1128/JVI.02062-10
- Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. 2010. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 84: 12658-12664. https://doi.org/10.1128/JVI.01542-10
- Shirato K, Kawase M, Matsuyama S. 2013. Middle east respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J. Virol. 87: 12552-12561. https://doi.org/10.1128/JVI.01890-13
- Limburg H, Harbig A, Bestle D, Stein DA, Moulton HM, Jaeger J, et al. 2019. TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes. J. Virol. 93: e00649-19.
- Zhao MM, Zhu Y, Zhang L, Zhong G, Tai L, Liu S, et al. 2022. Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies. Cell Discov. 8: 53.
- Ou T, Mou H, Zhang L, Ojha A, Choe H, Farzan M. 2021. Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. PLoS Pathog. 17: e1009212. https://doi.org/10.1371/journal.ppat.1009212
- Bayati A, Kumar R, Francis V, McPherson PS. 2021. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem. 296: 100306. https://doi.org/10.1016/j.jbc.2021.100306
- Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181: 271-280 e278. https://doi.org/10.1016/j.cell.2020.02.052
- WHO. 2022. Tracking SARS-CoV-2 variants. Available from https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. Accessed 03 February, 2022.
- Magazine N, Zhang T, Wu Y, McGee MC, Veggiani G, Huang W. 2022. Mutations and evolution of the SARS-CoV-2 spike protein. Viruses 14: 640. https://doi.org/10.3390/v14030640
- McCallum M, De Marco A, Lempp FA, Tortorici MA, Pinto D, Walls AC, et al. 2021. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184: 2332-2347.e16. https://doi.org/10.1016/j.cell.2021.03.028
- Gobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, et al. 2021. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science 373: eabi6226. https://doi.org/10.1126/science.abi6226
- Hikmet F, Mear L, Edvinsson A, Micke P, Uhlen M, Lindskog C. 2020. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16: e9610. https://doi.org/10.15252/msb.20209610
- Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. 2020. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181: 1016-1035.e.19. https://doi.org/10.1016/j.cell.2020.04.035
- Liu J, Li Y, Liu Q, Yao Q, Wang X, Zhang H, et al. 2021. SARS-CoV-2 cell tropism and multiorgan infection. Cell Discov. 7: 17.
- Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. 2020. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158: 1831-1833.e3. https://doi.org/10.1053/j.gastro.2020.02.055
- Sun J, Zhu A, Li H, Zheng K, Zhuang Z, Chen Z, et al. 2020. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg. Microbes Infect. 9: 991-993. https://doi.org/10.1080/22221751.2020.1760144
- Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. 2020. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 46: 1339-1348. https://doi.org/10.1007/s00134-020-06153-9
- Salamanna F, Maglio M, Landini MP, Fini M. 2020. Body localization of ACE-2: On the trail of the Keyhole of SARS-CoV-2. Front. Med (Lausanne). 7: 594495. https://doi.org/10.3389/fmed.2020.594495
- Eslami N, Aghbash PS, Shamekh A, Entezari-Maleki T, Nahand JS, Sales AJ, et al. 2022. SARS-CoV-2: receptor and co-receptor tropism probability. Curr. Microbiol. 79: 133. https://doi.org/10.1007/s00284-022-02807-7
- van der Velden VH, Wierenga-Wolf AF, Adriaansen-Soeting PW, Overbeek SE, Moller GM, Hoogsteden HC, et al. 1998. Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus. Clin. Exp. Allergy 28: 110-120. https://doi.org/10.1046/j.1365-2222.1998.028s5110.x
- Kindler E, Jonsdottir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, et al. 2013. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio 4: e00611-00612.
- Lambeir AM, Durinx C, Scharpe S, De Meester I. 2003. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 40: 209-294. https://doi.org/10.1080/713609354
- Subissi L, Posthuma CC, Collet A, Zevenhoven-Dobbe JC, Gorbalenya AE, Decroly E, et al. 2014. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc. Natl. Acad. Sci. USA 111: E3900-3909.
- te Velthuis AJ, Arnold JJ, Cameron CE, van den Worm SH, Snijder EJ. 2010. The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent. Nucleic. Acids Res. 38: 203-214. https://doi.org/10.1093/nar/gkp904
- Ahn DG, Choi JK, Taylor DR, Oh JW. 2012. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates. Arch. Virol. 157: 2095-2104. https://doi.org/10.1007/s00705-012-1404-x
- Kirchdoerfer RN, Ward AB. 2019. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat. Commun. 10: 2342. https://doi.org/10.1038/s41467-019-10280-3
- Bouvet M, Imbert I, Subissi L, Gluais L, Canard B, Decroly E. 2012. RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex. Proc. Natl. Acad. Sci. USA 109: 9372-9377. https://doi.org/10.1073/pnas.1201130109
- Bouvet M, Lugari A, Posthuma CC, Zevenhoven JC, Bernard S, Betzi S, et al. 2014. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. J. Biol. Chem. 289: 25783-25796. https://doi.org/10.1074/jbc.M114.577353
- Yin W, Mao C, Luan X, Shen DD, Shen Q, Su H, et al. 2020. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368: 1499-1504. https://doi.org/10.1126/science.abc1560
- Hillen HS, Kokic G, Farnung L, Dienemann C, Tegunov D, Cramer P. 2020. Structure of replicating SARS-CoV-2 polymerase. Nature 584: 154-156. https://doi.org/10.1038/s41586-020-2368-8
- Naydenova K, Muir KW, Wu LF, Zhang Z, Coscia F, Peet MJ, et al. 2021. Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP. Proc. Natl. Acad. Sci. USA 118: e2021946118. https://doi.org/10.1073/pnas.2021946118
- Maio N, Lafont BAP, Sil D, Li Y, Bollinger JM, Jr., Krebs C, et al. 2021. Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets. Science 373: 236-241. https://doi.org/10.1126/science.abi5224
- Riccio AA, Sullivan ED, Copeland WC. 2022. Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors. J. Biol. Chem. 298: 101518. https://doi.org/10.1016/j.jbc.2021.101518
- Czarna A, Plewka J, Kresik L, Matsuda A, Karim A, Robinson C, et al. 2022. Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity. Structure 30: 1050-5041.e2. https://doi.org/10.1016/j.str.2022.04.014
- Moeller NH, Shi K, Demir O, Belica C, Banerjee S, Yin L, et al. 2022. Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN. 119: e2106379119.
- Rona G, Zeke A, Miwatani-Minter B, de Vries M, Kaur R, Schinlever A, et al. 2022. The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target. Cell Death Differ. 29: 285-292. https://doi.org/10.1038/s41418-021-00900-1
- Eckerle LD, Lu X, Sperry SM, Choi L, Denison MR. 2007. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 81: 12135-12144. https://doi.org/10.1128/JVI.01296-07
- Eckerle LD, Becker MM, Halpin RA, Li K, Venter E, Lu X, et al. 2010. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 6: e1000896. https://doi.org/10.1371/journal.ppat.1000896
- Ogando NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, Posthuma CC, Snijder EJ. 2020. The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J. Virol. 94: e01246-20.
- Brierley I, Digard P, Inglis SC. 1989. Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell 57: 537-547. https://doi.org/10.1016/0092-8674(89)90124-4
- Plant EP, Dinman JD. 2008. The role of programmed-1 ribosomal frameshifting in coronavirus propagation. Front. Biosci. 13: 4873-4881. https://doi.org/10.2741/3046
- Plant EP, Sims AC, Baric RS, Dinman JD, Taylor DR. 2013. Altering SARS coronavirus frameshift efficiency affects genomic and subgenomic RNA production. Viruses 5: 279-294. https://doi.org/10.3390/v5010279
- Kelly JA, Olson AN, Neupane K, Munshi S, San Emeterio J, Pollack L, et al. 2020. Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2). J. Biol. Chem. 295: 10741-10748. https://doi.org/10.1074/jbc.ac120.013449
- Ahn DG, Yoon GY, Lee S, Ku KB, Kim C, Kim KD, et al. 2021. A Novel Frameshifting inhibitor having antiviral activity against zoonotic coronaviruses. Viruses 13: 1639. https://doi.org/10.3390/v13081639
- Plant EP, Perez-Alvarado GC, Jacobs JL, Mukhopadhyay B, Hennig M, Dinman JD. 2005. A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal. PLoS Biol. 3: e172. https://doi.org/10.1371/journal.pbio.0030172
- Irigoyen N, Firth AE, Jones JD, Chung BY, Siddell SG, Brierley I. 2016. High-resolution analysis of coronavirus gene expression by RNA sequencing and ribosome profiling. PLoS Pathog. 12: e1005473. https://doi.org/10.1371/journal.ppat.1005473
- Wacker A, Weigand JE, Akabayov SR, Altincekic N, Bains JK, Banijamali E, et al. 2020. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy. Nucleic Acids Res. 48: 12415-12435. https://doi.org/10.1093/nar/gkaa1013
- Roman C, Lewicka A, Koirala D, Li NS, Piccirilli JA. 2021. The SARS-CoV-2 programmed -1 ribosomal frameshifting element crystal structure solved to 2.09 A using chaperone-assisted RNA crystallography. ACS Chem. Biol. 16: 1469-1481. https://doi.org/10.1021/acschembio.1c00324
- Zhang K, Zheludev IN, Hagey RJ, Haslecker R, Hou YJ, Kretsch R, et al. 2021. Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome. Nat. Struct. Mol. Biol. 28: 747-754. https://doi.org/10.1038/s41594-021-00653-y
- Haniff HS, Tong Y, Liu X, Chen JL, Suresh BM, Andrews RJ, et al. 2020. Targeting the SARS-CoV-2 RNA genome with small molecule binders and ribonuclease targeting chimera (RIBOTAC) degraders. ACS Cent. Sci. 6: 1713-1721. https://doi.org/10.1021/acscentsci.0c00984
- Munshi S, Neupane K, Ileperuma SM, Halma MTJ, Kelly JA, Halpern CF, et al. 2022. Identifying inhibitors of -1 programmed ribosomal frameshifting in a broad spectrum of coronaviruses. Viruse 14: 177. https://doi.org/10.3390/v14020177
- Sun Y, Abriola L, Niederer RO, Pedersen SF, Alfajaro MM, Silva Monteiro V, et al. 2021. Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting. Proc. Natl. Acad. Sci. USA 118: e2023051118. https://doi.org/10.1073/pnas.2023051118
- Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L, et al. 2020. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine 61: 103104. https://doi.org/10.1016/j.ebiom.2020.103104
- Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. 2020. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382: 727-733. https://doi.org/10.1056/nejmoa2001017
- Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, et al. 2021. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 40: e107405. https://doi.org/10.15252/embj.2020107405
- Zhu N, Wang W, Liu Z, Liang C, Wang W, Ye F, et al. 2020. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat. Commun. 11: 3910. https://doi.org/10.1038/s41467-020-17796-z
- Wolff G, Limpens R, Zevenhoven-Dobbe JC, Laugks U, Zheng S, de Jong AWM, et al. 2020. A molecular pore spans the double membrane of the coronavirus replication organelle. Science 369: 1395-1398. https://doi.org/10.1126/science.abd3629
- Ren Y, Shu T, Wu D, Mu J, Wang C, Huang M, et al. 2020. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell. Mol. Immunol. 17: 881-883. https://doi.org/10.1038/s41423-020-0485-9
- Freundt EC, Yu L, Goldsmith CS, Welsh S, Cheng A, Yount B, et al. 2010. The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death. J. Virol. 84: 1097-1109. https://doi.org/10.1128/JVI.01662-09
- Law PTW, Wong CH, Au TCC, Chuck CP, Kong SK, Chan PKS, et al. 2005. The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. J. Gen. Virol. 86: 1921-1930. https://doi.org/10.1099/vir.0.80813-0
- Li F, Li J, Wang PH, Yang N, Huang J, Ou J, et al. 2021. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim. Biophys. Acta Mol. Basis Dis. 1867: 166260. https://doi.org/10.1016/j.bbadis.2021.166260
- Rashid F, Dzakah EE, Wang H, Tang S. 2021. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta. Virus Res. 296: 198350. https://doi.org/10.1016/j.virusres.2021.198350
- Shang C, Liu Z, Zhu Y, Lu J, Ge C, Zhang C, et al. 2021. SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Front. Microbiol. 12: 780768.
- Meyer K, Patra T, Vijayamahantesh, Ray R. 2021. SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesion in endothelial cells. J. Virol. 95: e0079421. https://doi.org/10.1128/JVI.00794-21
- Evangelou K, Veroutis D, Paschalaki K, Foukas PG, Lagopati N, Dimitriou M, et al. 2022. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis. Eur. Respir. J. 60: 2102951. https://doi.org/10.1183/13993003.02951-2021
- Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. 2020. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 31: 1068-1077. e1063. https://doi.org/10.1016/j.cmet.2020.04.021
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054-1062. https://doi.org/10.1016/s0140-6736(20)30566-3
- Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. 2020. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 395: 1763-1770. https://doi.org/10.1016/s0140-6736(20)31189-2
- Tang X, Uhl S, Zhang T, Xue D, Li B, Vandana JJ, et al. 2021. SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metab. 33: 1577-1591.e7. https://doi.org/10.1016/j.cmet.2021.05.015
- Fung TS, Liu DX. 2014. Coronavirus infection, ER stress, apoptosis and innate immunity. Front. Microbiol. 5: 296. https://doi.org/10.3389/fmicb.2014.00296
- Bull JJ, Lauring AS. 2014. Theory and empiricism in virulence evolution. PLoS Pathog. 10: e1004387. https://doi.org/10.1371/journal.ppat.1004387
- Xia S, Liu Q, Wang Q, Sun Z, Su S, Du L, et al. 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res. 194: 200-210. https://doi.org/10.1016/j.virusres.2014.10.007
- Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. 2020. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 10: 766-788. https://doi.org/10.1016/j.apsb.2020.02.008
- Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102: 11876-11881. https://doi.org/10.1073/pnas.0505577102
- Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S. 2012. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J. Virol. 86: 6537-6545. https://doi.org/10.1128/JVI.00094-12
- Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. 2020. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181: 281-292 e286. https://doi.org/10.1016/j.cell.2020.02.058
- Yang Y, Du L, Liu C, Wang L, Ma C, Tang J, et al. 2014. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc. Natl. Acad. Sci. USA 111: 12516-12521. https://doi.org/10.1073/pnas.1405889111
- Belouzard S, Millet JK, Licitra BN, Whittaker GR. 2012. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4: 1011-1033. https://doi.org/10.3390/v4061011
- Li F. 2016. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 3: 237-261. https://doi.org/10.1146/annurev-virology-110615-042301
- Schoeman D, Fielding BC. 2019. Coronavirus envelope protein: current knowledge. Virol. J. 16: 69. https://doi.org/10.1186/s12985-019-1182-0
- DeDiego ML, Nieto-Torres JL, Jimenez-Guardeno JM, Regla-Nava JA, Alvarez E, Oliveros JC, et al. 2011. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog. 7: e1002315. https://doi.org/10.1371/journal.ppat.1002315
- Nieto-Torres JL, DeDiego ML, Verdia-Baguena C, Jimenez-Guardeno JM, Regla-Nava JA, Fernandez-Delgado R, et al. 2014. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 10: e1004077. https://doi.org/10.1371/journal.ppat.1004077
- Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, Ito N, et al. 2006. Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc. Natl. Acad. Sci. USA103: 12885-12890.
- Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, Tseng CT, et al. 2008. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 82: 4471-4479. https://doi.org/10.1128/JVI.02472-07
- Russo LC, Tomasin R, Matos IA, Manucci AC, Sowa ST, Dale K, et al. 2021. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling. J. Biol. Chem. 297: 101041. https://doi.org/10.1016/j.jbc.2021.101041
- Forni D, Cagliani R, Mozzi A, Pozzoli U, Al-Daghri N, Clerici M, et al. 2016. Extensive positive selection erives the evolution of nonstructural proteins in lineage C betacoronaviruses. J. Virol. 90: 3627-3639. https://doi.org/10.1128/JVI.02988-15
- Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, et al. 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587: 657-662. https://doi.org/10.1038/s41586-020-2601-5
- Au-Yeung N, Horvath CM. 2018. Transcriptional and chromatin regulation in interferon and innate antiviral gene expression. Cytokine Growth Factor Rev. 44: 11-17. https://doi.org/10.1016/j.cytogfr.2018.10.003
- Huangfu WC, Fuchs SY. 2010. Ubiquitination-dependent regulation of signaling receptors in cancer. Genes Cancer 1: 725-734. https://doi.org/10.1177/1947601910382901
- Akutsu M, Ye Y, Virdee S, Chin JW, Komander D. 2011. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc. Natl. Acad. Sci. USA 108: 2228-2233. https://doi.org/10.1073/pnas.1015287108
- Andrew AJ, Miyagi E, Kao S, Strebel K. 2009. The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology 6: 80. https://doi.org/10.1186/1742-4690-6-80
- Taylor JK, Coleman CM, Postel S, Sisk JM, Bernbaum JG, Venkataraman T, et al. 2015. Severe acute respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion tethering through a novel mechanism of glycosylation interference. J. Virol. 89: 11820-11833. https://doi.org/10.1128/JVI.02274-15
- Thorne LG, Reuschl AK, Zuliani-Alvarez L, Whelan MVX, Turner J, Noursadeghi M, et al. 2021. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J. 40: e107826. https://doi.org/10.15252/embj.2021107826
- Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G, et al. 2021. TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection. Microorganisms 9: 1820. https://doi.org/10.3390/microorganisms9091820
- Xagorari A, Chlichlia K. 2008. Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol. J. 2: 49-59. https://doi.org/10.2174/1874285800802010049
- Scheuplein VA, Seifried J, Malczyk AH, Miller L, Hocker L, Vergara-Alert J, et al. 2015. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J. Virol. 89: 3859-3869. https://doi.org/10.1128/JVI.03607-14
- Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, et al. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109: 1131-1137. https://doi.org/10.1182/blood-2006-05-023770
- Mdkhana B, Saheb Sharif-Askari N, Ramakrishnan RK, Goel S, Hamid Q, Halwani R. 2021. Nucleic acid-sensing pathways during SARS-CoV-2 infection: Expectations versus reality. J. Inflamm. Res. 14: 199-216. https://doi.org/10.2147/JIR.S277716
- Zhao Z, Wei Y, Tao C. 2021. An enlightening role for cytokine storm in coronavirus infection. Clin. Immunol. 222: 108615. https://doi.org/10.1016/j.clim.2020.108615
- Wang J, Jiang M, Chen X, Montaner LJ. 2020. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc Biol. 108: 17-41. https://doi.org/10.1002/JLB.3COVR0520-272R
- Beyer DK, Forero A. 2022. Mechanisms of antiviral immune evasion of SARS-CoV-2. J. Mol. Biol. 434: 167265. https://doi.org/10.1016/j.jmb.2021.167265
- Park A, Iwasaki A. 2020. Type I and Type III interferons - Induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe. 27: 870-878. https://doi.org/10.1016/j.chom.2020.05.008
- Oudshoorn D, Rijs K, Limpens R, Groen K, Koster AJ, Snijder EJ, et al. 2017. Expression and cleavage of middle east respiratory syndrome coronavirus nsp3-4 polyprotein induce the formation of double-membrane vesicles that mimic those associated with coronaviral RNA replication. mBio 8: e01658-17.
- Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. 2013. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio 4: e00524-13.
- Klein S, Cortese M, Winter SL, Wachsmuth-Melm M, Neufeldt CJ, Cerikan B, et al. 2020. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat. Commun. 11: 5885. https://doi.org/10.1038/s41467-020-19619-7
- Li JY, Zhou ZJ, Wang Q, He QN, Zhao MY, Qiu Y, et al. 2021. Innate immunity evasion strategies of highly pathogenic coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2. Front. Microbiol. 12: 770656. https://doi.org/10.3389/fmicb.2021.770656
- Chang LJ, Chen TH. 2021. NSP16 2'-O-MTase in coronavirus pathogenesis: Possible prevention and treatments strategies. Viruses 13: 538. https://doi.org/10.3390/v13040538
- Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, et al. 2009. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl. Acad. Sci. USA 106: 3484-3489. https://doi.org/10.1073/pnas.0808790106
- Viswanathan T, Arya S, Chan SH, Qi S, Dai N, Misra A, et al. 2020. Structural basis of RNA cap modification by SARS-CoV-2. Nat. Commun. 11: 3718. https://doi.org/10.1038/s41467-020-17496-8
- Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A, et al. 2012. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7: e43031. https://doi.org/10.1371/journal.pone.0043031
- Nakagawa K, Narayanan K, Wada M, Makino S. 2018. Inhibition of stress granule formation by middle east respiratory syndrome coronavirus 4a accessory protein facilitates viral translation, leading to efficient virus replication. J. Virol. 92: e00902-18.
- Gao B, Gong X, Fang S, Weng W, Wang H, Chu H, et al. 2021. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication. PLoS Pathog. 17: e1008690. https://doi.org/10.1371/journal.ppat.1008690
- Zheng ZQ, Wang SY, Xu ZS, Fu YZ, Wang YY. 2021. SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication. Cell Discov. 7: 38.
- Chen K, Xiao F, Hu D, Ge W, Tian M, Wang W, et al. 2020. SARS-CoV-2 Nucleocapsid protein interacts with RIG-I and represses RIG-mediated IFN-beta production. Viruses 13: 47. https://doi.org/10.3390/v13010047
- Michalska A, Blaszczyk K, Wesoly J, Bluyssen HAR. 2018. A positive feedback amplifier circuit that regulates interferon (IFN)-stimulated gene expression and controls type I and type II IFN responses. Front. Immunol. 9: 1135. https://doi.org/10.3389/fimmu.2018.01135
- Yang X, Chen X, Bian G, Tu J, Xing Y, Wang Y, et al. 2014. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. J. Gen. Virol. 95: 614-626. https://doi.org/10.1099/vir.0.059014-0
- Devaraj SG, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, et al. 2007. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282: 32208-32221. https://doi.org/10.1074/jbc.M704870200
- Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS. 2009. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J. Virol. 83: 6689-6705. https://doi.org/10.1128/JVI.02220-08
- Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, et al. 2020. Evasion of Type I interferon by SARS-CoV-2. Cell Rep. 33: 108234. https://doi.org/10.1016/j.celrep.2020.108234
- Yang Y, Ye F, Zhu N, Wang W, Deng Y, Zhao Z, et al. 2015. Middle east respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci. Rep. 5: 17554. https://doi.org/10.1038/srep17554
- Gao X, Zhu K, Qin B, Olieric V, Wang M, Cui S. 2021. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions. Nat. Commun. 12: 2843. https://doi.org/10.1038/s41467-021-23118-8
- Hayn M, Hirschenberger M, Koepke L, Nchioua R, Straub JH, Klute S, et al. 2021. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. 35: 109126. https://doi.org/10.1016/j.celrep.2021.109126
- Minakshi R, Padhan K, Rani M, Khan N, Ahmad F, Jameel S. 2009. The SARS coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS One 4: e8342. https://doi.org/10.1371/journal.pone.0008342
- Miorin L, Kehrer T, Sanchez-Aparicio MT, Zhang K, Cohen P, Patel RS, et al. 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc. Natl. Acad. Sci. USA 117: 28344-28354. https://doi.org/10.1073/pnas.2016650117
- Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P. 2007. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 81: 548-557. https://doi.org/10.1128/JVI.01782-06
- Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. 2021. Post-acute COVID-19 syndrome. Nat. Med. 27: 601-615. https://doi.org/10.1038/s41591-021-01283-z
- Brodin P, Casari G, Townsend L, O'Farrelly C, Tancevski I, Loffler-Ragg J, et al. 2022. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 28: 879-882. https://doi.org/10.1038/s41591-022-01766-7
- Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. 2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2: e13-e22. https://doi.org/10.1016/S2666-5247(20)30172-5
- Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, et al. 2020. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 382: 2081-2090. https://doi.org/10.1056/nejmoa2008457
- Park WB, Poon LLM, Choi SJ, Choe PG, Song KH, Bang JH, et al. 2018. Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection. Int. J. Infect. Dis. 72: 8-10. https://doi.org/10.1016/j.ijid.2018.05.003
- Oh MD, Park WB, Choe PG, Choi SJ, Kim JI, Chae J, et al. 2016. Viral load kinetics of MERS coronavirus infection. N. Engl. J. Med. 375: 1303-1305. https://doi.org/10.1056/NEJMc1511695
- Xu D, Zhang Z, Jin L, Chu F, Mao Y, Wang H, et al. 2005. Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur. J. Clin. Microbiol. Infect. Dis. 24: 165-171. https://doi.org/10.1007/s10096-005-1299-5
- Liu W, Tang F, Fontanet A, Zhan L, Zhao QM, Zhang PH, et al. 2004. Long-term SARS coronavirus excretion from patient cohort, China. Emerg. Infect. Dis. 10: 1841-1843. https://doi.org/10.3201/eid1010.040297
- Christensen BB, Azar MM, Turbett SE. 2022. Laboratory diagnosis for SARS-CoV-2 infection. Infect. Dis. Clin. North Am. 36: 327-347. https://doi.org/10.1016/j.idc.2022.02.002
- Dalia Arostegui KC, Steven Schwarz, Katherine Vaidy, Simon Rabinowitz, Thomas Wallach. 2022. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. JPGN Rep. 3: e152. https://doi.org/10.1097/PG9.0000000000000152
- Wang X, Zhou Y, Jiang N, Zhou Q, Ma WL. 2020. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved. Int. J. Infect. Dis. 95: 433-435. https://doi.org/10.1016/j.ijid.2020.04.063
- Chan PK, To KF, Lo AW, Cheung JL, Chu I, Au FW, et al. 2004. Persistent infection of SARS coronavirus in colonic cells in vitro. J. Med. Virol. 74: 1-7. https://doi.org/10.1002/jmv.20138
- Pacciarini F, Ghezzi S, Canducci F, Sims A, Sampaolo M, Ferioli E, et al. 2008. Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein. J. Virol. 82: 5137-5144. https://doi.org/10.1128/JVI.00096-08
- Mizutani T, Fukushi S, Ishii K, Sasaki Y, Kenri T, Saijo M, et al. 2006. Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochem. Biophys. Res. Commun. 347: 261-265. https://doi.org/10.1016/j.bbrc.2006.06.086
- Lee S, Yoon GY, Myoung J, Kim SJ, Ahn DG. 2020. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Emerg. Microbes Infect. 9: 2169-2179. https://doi.org/10.1080/22221751.2020.1827985
- Kanwugu ON, Adadi P. 2021. HIV/SARS-CoV-2 coinfection: A global perspective. J. Med. Virol. 93: 726-732. https://doi.org/10.1002/jmv.26321
- Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, et al. 2021. Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health Organization (WHO) clinical characterization protocol (UK): A prospective observational study. Clin. Infect. Dis. 73: e2095-e2106. https://doi.org/10.1093/cid/ciaa1605
- Davies MA. 2020. HIV and risk of COVID-19 death: a population cohort study from the Western cape province, South Africa. medRxiv. doi: 10.1101/2020.07.02.20145185. Preprint.
- Swets MC, Russell CD, Harrison EM, Docherty AB, Lone N, Girvan M, et al. 2022. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet 399: 1463-1464. https://doi.org/10.1016/S0140-6736(22)00383-X
- F Karim MM, BI Gosnell, S Cele, J Giandhari, S Pillay, H Tegally, et al. 2021. Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection. medRxiv. doi: https://doi.org/10.1101/2021.06.03.21258228.
- Qureshi AI, Baskett WI, Huang W, Lobanova I, Hasan Naqvi S, Shyu CR. 2022. Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients undergoing serial laboratory testing. Clin. Infect. Dis. 74: 294-300. https://doi.org/10.1093/cid/ciab345
- Nguyen NN, Houhamdi L, Hoang VT, Delerce J, Delorme L, Colson P, et al. 2022. SARS-CoV-2 reinfection and COVID-19 severity. Emerg. Microbes Infect. 11: 894-901. https://doi.org/10.1080/22221751.2022.2052358
- Baang JH, Smith C, Mirabelli C, Valesano AL, Manthei DM, Bachman MA, et al. 2021. Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient. J. Infect. Dis. 223: 23-27. https://doi.org/10.1093/infdis/jiaa666
- Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. 2020. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 383: 2291-2293. https://doi.org/10.1056/nejmc2031364
- Frampton D, Rampling T, Cross A, Bailey H, Heaney J, Byott M, et al. 2021. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect. Dis. 21: 1246-1256. https://doi.org/10.1016/S1473-3099(21)00170-5
- Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DDS, Mishra S, et al. 2021. Genomics and epidemiology of the P.1 SARSCoV-2 lineage in Manaus, Brazil. Science 372: 815-821. https://doi.org/10.1126/science.abh2644
- Lorenzo-Redondo R, Nam HH, Roberts SC, Simons LM, Jennings LJ, Qi C, et al. 2020. A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways. EBioMedicine 62: 103112. https://doi.org/10.1016/j.ebiom.2020.103112
- Zhao S, Lou J, Cao L, Zheng H, Chong MKC, Chen Z, et al. 2021. Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis. J. Travel Med. 28: taab001. https://doi.org/10.1093/jtm/taab001
- Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, et al. 2021. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 372: eabg3055. https://doi.org/10.1126/science.abg3055
- Kim YJ, Jang US, Soh SM, Lee JY, Lee HR. 2021. The impact on infectivity and neutralization efficiency of SARS-CoV-2 lineage B.1.351 pseudovirus. Viruses 13: 633. https://doi.org/10.3390/v13040633
- Deng X, Garcia-Knight MA, Khalid MM, Servellita V, Wang C, Morris MK, et al. 2021. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant. Cell 184: 3426-3437. e8. https://doi.org/10.1016/j.cell.2021.04.025
- Yao H, Lu X, Chen Q, Xu K, Chen Y, Cheng M, et al. 2020. Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discov. 6: 76.
- Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, et al. 2020. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182: 1284-1294. e9. https://doi.org/10.1016/j.cell.2020.07.012
- Young BE, Wei WE, Fong SW, Mak TM, Anderson DE, Chan YH, et al. 2021. Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study. EBioMedicine 66: 103319. https://doi.org/10.1016/j.ebiom.2021.103319
- Stauft CB, Lien CZ, Selvaraj P, Liu S, Wang TT. 2021. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters. Virology 556: 96-100. https://doi.org/10.1016/j.virol.2021.01.005
- Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. 2005. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. USA 102: 7988-7993. https://doi.org/10.1073/pnas.0409465102
- Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, et al. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357: 420-422. https://doi.org/10.1038/357420a0
- Tresnan DB, Levis R, Holmes KV. 1996. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J. Virol. 70: 8669-8674. https://doi.org/10.1128/jvi.70.12.8669-8674.1996
- Williams RK, Jiang GS, Holmes KV. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88: 5533-5536. https://doi.org/10.1073/pnas.88.13.5533